Bank of America A spokesperson for the Charlotte, North Carolina-headquartered bank said the firm does not require new hires or current employees to test for drug use. Documents posted on the ...
An “old man test” — which challenges people to ready ... obesity and unhealthy cholesterol levels. Most alarming of all, those who were unable to successfully balance for 10 seconds had ...
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...
Issues relating to your kidneys, liver, pancreas, or heart can all be flagged by an abnormal urine test result. This article reviews what kinds of things routine urine tests check for, as well as ...
For some perspective, as of June 2024, the FDA received 1,516 requests for this designation, and only 587 have been granted. This is in line with previous years, during which around 30-40% of ...
Tryngolza is once-monthly, subcutaneous RNA-targeted therapy and is expected to be available by the end of the year with a price of $595,000. The FDA has approved Tryngolza (olezarsen) to reduce ...
Improving access to nutrition information is an important public health effort the FDA can undertake to help people build healthy eating patterns,” FDA Commissioner Dr. Robert Califf said in a ...
Chief Government Whip and Health and Media Minister, Dr. Nalinda Jayatissa stated in Parliament yesterday that the Health Ministry is investigating fraud committed in the purchase of rapid antigen ...
Chelsea Football Club revealed today that one of their players, Mykhailo Mudryk, has tested positive for a banned substance in a routine drug test. Meldonium first became known to sports fans in ...
During this year's third quarter, the drug generated $392 million in U.S. sales. Meanwhile, a new threat has emerged for the original version of Eylea as Amgen recently launched its biosimilar ...
But in a study published in Science Advances, researchers at Case Western Reserve University describe how they may have found a new target: a cholesterol-managing protein called PfNCR1.